Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 0 | 22,000 | 95,000 | 156,000 | 114.1M | 0 | 0 |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -209.3M | -273.2M | -327.7M | -335.5M | -180.2M | -258.2M | -202.0M |
| EBITDA | -197.0M | -259.6M | -313.5M | -321.2M | -169.7M | -250.8M | -197.4M |
| Net Income | -190.9M | -257.6M | -327.3M | -340.4M | -182.1M | -316.4M | -184.6M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 221M | 195M | 157M | 143M | 136M | 120M | 101M |
Allogene Therapeutics Inc. Income Statement — FAQ
Allogene Therapeutics Inc. (ALLO) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALLO's income statement history?
The chart and table above show Allogene Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.